S&P 500
(0.06%) 5 073.80 points
Dow Jones
(-0.02%) 38 497 points
Nasdaq
(0.14%) 15 718 points
Oil
(-0.53%) $82.92
Gas
(-9.05%) $1.648
Gold
(-0.36%) $2 333.60
Silver
(-0.37%) $27.26
Platinum
(-0.99%) $913.65
USD/EUR
(0.02%) $0.934
USD/NOK
(0.76%) $10.99
USD/GBP
(-0.10%) $0.802
USD/RUB
(-0.98%) $92.28

Realtime updates for Avecho Biotechnology Ltd [AVE.AX]

Exchange: ASX Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated24 Apr 2024 @ 02:10

-20.00% $ 0.00400

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 02:10):

Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries...

Stats
Today's Volume 3.22M
Average Volume 4.60M
Market Cap 10.14M
EPS $0 ( 2024-02-27 )
Last Dividend $0.00878 ( 1997-05-19 )
Next Dividend $0 ( N/A )
P/E 0
ATR14 $0 (0.00%)

Avecho Biotechnology Ltd Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Avecho Biotechnology Ltd Financials

Annual 2023
Revenue: $473 551
Gross Profit: $-222 490 (-46.98 %)
EPS: $-0.00150
Q4 2023
Revenue: $27 112.00
Gross Profit: $-436 282 (-1 609.18 %)
EPS: $-0.000400
Q2 2023
Revenue: $446 439
Gross Profit: $213 792 (47.89 %)
EPS: $-0.00110
Q4 2022
Revenue: $371 021
Gross Profit: $235 976 (63.60 %)
EPS: $-0.000900

Financial Reports:

No articles found.

Avecho Biotechnology Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Avecho Biotechnology Ltd Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.00878 1997-05-19
Last Dividend $0.00878 1997-05-19
Next Dividend $0 N/A
Payout Date 1997-06-06
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.00878 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-04-24)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
MXT.AX Ex Dividend Knight 2023-08-31 Monthly 0 0.00%
WBC.AX Ex Dividend Junior 2023-05-11 Annually 0 0.00%
EHL.AX Ex Dividend Knight 2023-09-07 Sporadic 0 0.00%
PCG.AX Ex Dividend Junior 2023-08-29 Annually 0 0.00%
ALU.AX Ex Dividend Knight 2023-09-04 Semi-Annually 0 0.00%
GUD.AX Ex Dividend Knight 2023-08-25 Semi-Annually 0 0.00%
RFF.AX Ex Dividend Knight 2023-09-28 Quarterly 0 0.00%
BRG.AX Ex Dividend Knight 2023-09-13 Semi-Annually 0 0.00%
KSL.AX Ex Dividend Knight 2023-09-06 Semi-Annually 0 0.00%
SRV.AX Ex Dividend Knight 2023-09-04 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-7.261.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-0.4701.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.8021.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM8.300.80010.008.00[1 - 3]
quickRatioTTM7.830.80010.008.00[0.8 - 2.5]
cashRatioTTM6.531.50010.0010.00[0.2 - 2]
debtRatioTTM0.0239-1.5009.60-10.00[0 - 0.6]
interestCoverageTTM-298.851.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM-0.001002.00-0.000334-0.000669[0 - 30]
freeCashFlowPerShareTTM-0.001002.00-0.000502-0.00100[0 - 20]
debtEquityRatioTTM0.0275-1.5009.89-10.00[0 - 2.5]
grossProfitMarginTTM-0.4701.000-10.00-10.00[0.2 - 0.8]
operatingProfitMarginTTM-9.691.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-18.161.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.06470.800-2.90-2.32[0.5 - 2]
Total Score-2.73

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-3.691.000-0.4740[1 - 100]
returnOnEquityTTM-0.8022.50-6.44-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-0.001002.00-0.000334-0.00100[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.001002.00-0.000334-0.000669[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.03391.500-3.560[0.5 - 2]
operatingCashFlowSalesRatioTTM-6.721.000-10.000[0.1 - 0.5]
Total Score-2.58

Avecho Biotechnology Ltd

Avecho Biotechnology Limited, a biotechnology company, develops, produces, and sells products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It also provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company has a collaboration with Lambert Initiative at the University of Sydney to conduct a study to examine whether topically applied cannabidiol can provide relief from symptoms of osteoarthritis. It serves customers in Australia, Switzerland, India, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 and is based in Clayton, Australia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators